赛诺菲的喜保宁在中国获批上市了吗？

It was approved for marketing in the UK in 1989 and was approved by the US Food and Drug Administration in 2009 for the treatment of infantile spasms and refractory focal epilepsy, making it one of the first-choice drugs for the treatment of infantile spasms, especially for patients with tuberous sclerosis.

Vigabatrin is a structural analog of gamma-aminobutyric acid (GABA). It inhibits the catabolism of GABA by irreversibly inhibiting GABA transaminase, thereby increasing the concentration of GABA in the brain and achieving anti-epileptic therapeutic effects. In foreign literature, the therapeutic dose of Vigabatrin is 0.10 to 0.15 g/(kg·d). It is generally effective 2 weeks after the initial treatment, which is manifested by the reduction or disappearance of convulsive attacks and the disappearance of peak arrhythmia-like EEG.

Has Sanofi's Vigabatrin been approved for marketing in China? Sanofi Vigabatrin has been launched in many countries and regions, but it has not yet been approved for official launch in China because it is not listed and does not qualify for national medical insurance. If patients want to purchase the drug, they can only choose to go abroad to purchase the drug. Traveling abroad to buy medicines is a long journey and requires a lot of manpower and material resources. Coupled with the huge medical expenses, it has brought a huge burden to many patients' families.

Currently on the market more patients are keen on Sanofi's. Sanofi (NYSE: SNY) was founded in 1973. Its predecessor was Sanofi-Aventis. It was changed to its current name: Sanofi in May 2011. It is headquartered in Paris, France, and has 113,496 full-time employees in more than 100 countries around the world. It is the world's leading diversified pharmaceutical and health company with diversified products, including drugs, vaccines and innovative treatment solutions. According to Medical Companion Travel, the specification of Sanofi Vigabatrin is 500mg*100 capsules/box, and the price is equivalent to RMB 1,450. Since the exchange rate has been in a state of fluctuation for a long time, the price fluctuates with the exchange rate and is not static. For more information about Vigabatrin, please contact Medical Companion Travel for details.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.